Pandrug-resistant Acinetobacter baumannii treatment: still a debatable topic with no definite solutions

Affiliations

¹ University Hospital of Ioannina, Intensive Care Unit, Stavros Niarchos Avenue, 45500 Ioannina, Greece.
² Burns, Trauma and Critical Care Research Centre, UQ Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Herston Campus, Brisbane QLD 4029, Australia.
³ 2nd Critical Care Department, Attikon University Hospital, Rimini Street, 12463 Athens, Greece.
⁴ Laboratory of Immunology and Microbiology, School of Medicine, University of Ioannina, Stavros Niarchos Avenue, 45500 Ioannina, Greece.

Comment

Georgios Papathanakos et al. J Antimicrob Chemother. 2020.

. 2020 Oct 1;75(10):3081.

doi: 10.1093/jac/dkaa264.

¹ University Hospital of Ioannina, Intensive Care Unit, Stavros Niarchos Avenue, 45500 Ioannina, Greece.
² Burns, Trauma and Critical Care Research Centre, UQ Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Herston Campus, Brisbane QLD 4029, Australia.
³ 2nd Critical Care Department, Attikon University Hospital, Rimini Street, 12463 Athens, Greece.
⁴ Laboratory of Immunology and Microbiology, School of Medicine, University of Ioannina, Stavros Niarchos Avenue, 45500 Ioannina, Greece.

No abstract available

Comment on

Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options.
Karakonstantis S, Kritsotakis EI, Gikas A. Karakonstantis S, et al. J Antimicrob Chemother. 2020 Feb 1;75(2):271-282. doi: 10.1093/jac/dkz401. J Antimicrob Chemother. 2020. PMID: 31586417